TMVI rivalry ramps up as CardiAQ sues Neovasc
This article was originally published in Clinica
Executive Summary
Transcatheter mitral valve implantation (TMVI) has been dubbed the “new TAVI” – and exciting technology is not the only similarity, it seems. Another thing the sector seems to have in common is companies’ fierce defence of their intellectual property.